← Browse by Condition
Medical Condition

her2 positive recurrent or metastatic malignant solid tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT03842085 Phase 1
Recruiting

Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor

Enrollment
34 pts
Location
China
Sponsor
Beijing Mabworks Biotech Co., ...
View Trial →